Sg Americas Securities, LLC Prelude Therapeutics Inc Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024
BUY
$1.69 - $4.37 $22,139 - $57,247
13,100 New
13,100 $56,000
Q4 2021

Feb 07, 2022
SELL
$11.89 - $31.74 $103,335 - $275,852
-8,691 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$25.78 - $38.65 $224,053 - $335,907
8,691 New
8,691 $272,000

Others Institutions Holding PRLD

# of Institutions
72
Shares Held
35.7M
Call Options Held
500
Put Options Held
300
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $38.2M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email